Du Bingling
Head of Investor Relations, J.D. Health
Replay available
JD Health International Inc (OTC: JDHIF) Q4 2023 earnings conference call, held 2024-03-21. Replay captured from the company's public earnings webcast.

Head of Investor Relations, J.D. Health
Executive Director & Chief Executive Officer, J.D. Health
Chief Financial Officer, J.D. Health
Analyst, Goldman Sachs
Analyst, UBS
Analyst, CICC
Ladies and gentlemen, thank you for standing by. Welcome to the JDA Health International Incorporation 2023 Annual Result Conference call at this time. Our participants are in listen-only mode. After management's prepared remarks, there will be a question-and-answer session. Please note that this English simultaneous translation line will be in listen-only mode for the duration of the call, including the question-and-answer session if you wish to listen to the announcement's original statement. or ask a question during a Q&A session, you will need to be dialed in to the Chinese language line. I will now turn the call over to Ms. Du Bingling, Head of Investor Relations Team at J.D. Health. Please go ahead, Du Bingling. Thank you, operator. Hello, everyone, and welcome you to our 23 Annual Results Conference call. Joining us today are J.D. Health Executive Director, CEO, Mr. Jin Bing, the CFO, Ms. Deng Hui. Before we start, We'd like to remind you that today's discussion may contain forward-looking statements which involve a number of risks and uncertainties. Actual results and outcomes may differ materially from those mentioned in today's announcement and in this discussion. The company does not undertake any obligation to update this forward-looking information except as required by law. During today's call, management will discuss certain non-authorized financial measures for comparison purposes only. For definition of financial measures and reconciliation financial results, please refer to the annual results announcement for the year ended December 31st, 2023, issued yesterday. For today's call, will read the prepared remarks in Chinese and will only be accepting questions in Chinese during the question and answer session. A third party interpreter will provide sim...